Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Stocks Surge: Intel Shines on Dow’s 138-Point Day

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Trading higher for most of the day, stocks really started shooting up in afternoon trading as Wall Street weighed the likelihood that the Federal Reserve would start tapering stimulus efforts in the wake of weak economic data. Wall Street concluded that to be unlikely, and the Dow Jones Industrial Average (DJINDICES: ^DJI  ) gained 138 points, or 0.9%, to finish at 15,254. Intel's (NASDAQ: INTC  ) stock tacked on 4%, ending as the top performer in the blue-chip index.

Monday marks the second straight day of trading where Intel's stock closed with the Dow's best gains. On Friday, shares were able to finish in the black when the index as a whole was down more than 200 points. The news, which was unconfirmed as of last week, is now official: Intel will be providing the chips for Samsung's next Galaxy tablet. 

Pharmaceutical giant Merck (NYSE: MRK  ) didn't fare so poorly either on Monday, tacking on healthy 3.8% gains of its own after some very positive early results on small-scale testing of treatments for advanced melanoma. It appears that the new drug is able to somehow tell the body which cells were tumorous, enabling the immune system to attack the offending cells. Prior to this development, such cells had been undetectable by the human body.

No slouch in its own right, Microsoft (NASDAQ: MSFT  ) shares added 2% today to join Intel as a technology stock boosting the Dow. A tech analyst at Nomura Securities, Rick Sherlund, suggested that Microsoft spin off parts of its business -- like search engine Bing and gaming platform Xbox -- that weren't the company's core focus. Shareholders may be swayed by the argument, considering the stock's stagnant performance over the last decade. 

Lastly, one of only two stocks to lose ground in the index today, Bank of America (NYSE: BAC  ) shares slipped 0.8%. Shareholders are holding their breath to find out what a New York judge thinks of the bank's $8.5 billion settlement to resolve litigation over faulty mortgage-backed securities it sold to clients during the financial crisis.

When it comes to dominating markets, it doesn't get much better than Intel's position in the PC microprocessor arena. However, that market is maturing, and Intel finds itself in a precarious situation longer term if it doesn't find new avenues for growth. In this premium research report on Intel, a Motley Fool analyst runs through all of the key topics investors should understand about the chip giant. Click here now to learn more.

Read/Post Comments (0) | Recommend This Article (6)

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2469200, ~/Articles/ArticleHandler.aspx, 9/27/2016 9:56:53 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 40 minutes ago Sponsored by:
DOW 18,228.30 133.47 0.74%
S&P 500 2,159.93 13.83 0.64%
NASD 5,305.71 48.22 0.92%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/27/2016 4:45 PM
^DJI $18228.30 Up +133.47 +0.74%
BAC $15.29 Up +0.20 +1.33%
Bank of America CAPS Rating: ****
INTC $37.18 Up +0.53 +1.45%
Intel CAPS Rating: ****
MRK $62.57 Up +0.42 +0.68%
Merck and Co. CAPS Rating: ****
MSFT $57.95 Up +1.05 +1.85%
Microsoft CAPS Rating: ****